Comparison of cancer risk estimates based on a variety of risk assessment methodologies.
暂无分享,去创建一个
[1] B. Ames,et al. Paracelsus to parascience: the environmental cancer distraction. , 2000, Mutation research.
[2] J. Wiltse,et al. US Environmental Protection Agency's revised guidelines for Carcinogen Risk Assessment: incorporating mode of action data. , 1998, Mutation research.
[3] J. E. Bailey,et al. Food Quality Protection Act of 1996 , 2003 .
[4] D. Gaylor,et al. Quick estimate of the regulatory virtually safe dose based on the maximum tolerated dose for rodent bioassays. , 1995, Regulatory toxicology and pharmacology : RTP.
[5] F. Roe,et al. Safety evaluation of toothpaste containing chloroform. III. Long-term study in beagle dogs. , 1979, Journal of environmental pathology and toxicology.
[6] J J Chen,et al. Uncertainty in cancer risk estimates. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.
[7] L. Tuxen,et al. Integrated risk information system (IRIS) , 1990 .
[8] R. Bull,et al. Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[9] B. Ames,et al. What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database. , 1998, Drug metabolism reviews.
[10] E. Zeiger,et al. Handbook of Carcinogenic Potency and Genotoxicity Databases , 1996 .
[11] A M Jarabek,et al. The application of dosimetry models to identify key processes and parameters for default dose-response assessment approaches. , 1995, Toxicology letters.
[12] D. Barnes,et al. Reference dose (RfD): description and use in health risk assessments. , 1988, Regulatory toxicology and pharmacology : RTP.
[13] David G. Hoel,et al. Some Tautologous Aspects of the Comparison of Carcinogenic Potency in Rats and Mice , 1985 .
[14] D. Gaylor. Relationship between the shape of dose-response curves and background tumor rates. , 1992, Regulatory toxicology and pharmacology : RTP.
[15] A G Renwick. The use of an additional safety or uncertainty factor for nature of toxicity in the estimation of acceptable daily intake and tolerable daily intake values. , 1995, Regulatory toxicology and pharmacology : RTP.
[16] L. Gold,et al. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996. , 1999, Environmental health perspectives.
[17] A semiquantitative method for selection of safety factors in establishing OELs for pharmaceutical compounds , 1995 .
[18] D W Gaylor,et al. Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose. , 1998, Regulatory toxicology and pharmacology : RTP.